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Abstract
Differentiated vulvar intraepithelial neoplasia (dVIN) is a premalignant lesion that is known to progress rapidly to invasive carcinoma.
Accurate histological diagnosis is therefore crucial to allow appropriate treatment. To identify reliable diagnostic features, we evaluated
the inter-observer agreement in the histological assessment of dVIN, among a bi-national, multi-institutional group of pathologists. Two
investigators from Erasmus MC selected 36 hematoxylin-eosin-stained glass slides of dVIN and no-dysplasia, and prepared a list of 15
histological features of dVIN. Nine participating pathologists (i) diagnosed each slide as dVIN or no-dysplasia, (ii) indicated which
features they used for the diagnosis, and (iii) rated these features in terms of their diagnostic usefulness. Diagnoses rendered by > 50%
participants were taken as the consensus (gold standard). p53-immunohistochemistry (IHC) was performed for all cases, and the
expression patterns were correlated with the consensus diagnoses. Kappa (ĸ)-statistics were computed to measure inter-observer
agreements, and concordance of the p53-IHC patterns with the consensus diagnoses. For the diagnosis of dVIN, overall agreement
was moderate (ĸ = 0.42), and pair-wise agreements ranged from slight (ĸ = 0.10) to substantial (ĸ = 0.73). Based on the levels of
agreement and ratings of usefulness, the most helpful diagnostic features were parakeratosis, cobblestone appearance, chromatin
abnormality, angulated nuclei, atypia discernable under × 100, and altered cellular alignment. p53-IHC patterns showed substantial
concordance (ĸ = 0.67) with the consensus diagnoses. Histological interpretation of dVIN remains challenging with suboptimal inter-
observer agreement. We identified the histological features that may facilitate the diagnosis of dVIN. For cases with a histological
suspicion of dVIN, consensus-based pathological evaluation may improve the reliability of the diagnosis.
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Introduction
Differentiated vulvar intraepithelial neoplasia (dVIN) is the
immediate precursor of human papillomavirus (HPV)–inde-
pendent vulvar squamous cell carcinoma (VSCC), and is pos-
tulated to develop on the background of chronic dermatoses,
driven by TP53 mutations [1–4]. Recent literature suggests
that dVIN has an accelerated rate of progression to VSCC
(median interval: 41.4 months), and a high recurrence rate
[5–7]. In view of this, current treatment guidelines [8, 9] rec-
ommend surgical excision of lesions that are histologically
diagnosed as dVIN. Evidently, accurate histological diagnosis
is crucial to allow appropriate patient management.
On histology, distinguishing dVIN from dermatoses, such
as lichen sclerosus (LS), can present a challenge, as dVIN
often exhibits subtle atypical features that mimic the reactive
changes seen in chronic dermatoses [10–12]. The difficulty of
diagnosing dVIN can give rise to diagnostic variability, which
has the potential to critically affect treatment decisions [13,
14].
Although the diagnostic difficulty of dVIN has been ac-
knowledged in literature [2–5], there is insufficient data on
the inter-observer agreement in the histological assessment.
In a previous study, we established the features that helped
to reliably distinguish dVIN fromLS, and could be interpreted
with substantial agreement by pathologists at our center [15].
However, it remains to be determined whether similar level of
agreement can be achieved between pathologists from differ-
ent practice settings.
In the current study, therefore, we evaluated the inter-
observer agreement for the diagnosis, and in the interpretation
of histological features of dVIN, among a bi-national, multi-
institutional group of pathologists. We also assessed the per-
ception of the pathologists regarding the diagnostic usefulness
of the histological features. Our aim was to thereby identify
reliable diagnostic features that may facilitate the diagnosis of
dVIN. In addition, we correlated the immunohistochemical
expression patterns of p53 with the consensus histological
diagnoses, as this marker is frequently used as an ancillary
tool to support the histological diagnosis of dVIN.
Materials and methods
Study design
For the purpose of this study, two investigators (SDG and
PCEG) identified all vulvar lesions from 2010 to 2013, from
the electronic records of the Department of Pathology,
Erasmus MC. All of these lesions were from patients who
underwent vulvar biopsies or excisions at Erasmus MC.
Hematoxylin-eosin (HE)–stained slides of these lesions were
retrieved from the archives, and the histology was reviewed
by these investigators.
From this series, the investigators selected a set of 36 slides
for inclusion in this study. The selection was enriched for
lesions regarded as dVIN by the investigators on histology
review, since the aim was to evaluate inter-observer agree-
ment in dVIN. Furthermore, to provide a range of challenges
to the participants, the selection was prepared in a way to
include (i) lesions adjacent to VSCC, as well as standalone
lesions, and (ii) lesions with classical histology, which were
diagnostically straightforward, as well as lesions where the
distinction between dVIN and no-dysplasia could be difficult.
The selection did not comprise any slides with invasive carci-
noma, as presence of VSCC in the adjacent epithelium can be
considered by pathologists as a diagnostic clue for dVIN [14].
Therefore, of the 36 selected slides, 25 contained lesions
adjacent to VSCCs, and 11 contained standalone lesions. The
investigators had judged 26 (72%) slides as dVIN and 10
(28%) slides as no-dysplasia, comprising 6 lichen sclerosus
and 4 non-specific reactive lesions. The investigators per-
ceived 67% of the diagnoses as straightforward and 33% as
difficult.
The original diagnoses of these slides, or the diagnoses
rendered by the investigators on review were not used for
the analyses. For each slide, the diagnosis rendered by >
50% of the participants was taken as the consensus
diagnosis/gold standard.
For de-identification, all slides were re-labeled with opaque
stickers bearing a random number. No serial sections were
prepared. To ensure that all pathologists evaluated identical
areas, the regions of interest were marked on the glass slides
with red lines.
For all included slides, immunohistochemistry (IHC) was
conducted with (i) p16 (E6H4-clone, Ventana), to confirm
that the selection did not contain any HPV-related lesion,
and with (ii) p53 (Ventana), to correlate with the consensus
diagnosis. The IHC protocol is detailed in supplementary doc-
ument 1. IHC slides were read only by the investigators and
were not provided to the participants. IHC was scored and
interpreted as described below:
(i) p16-IHC patterns were scored as block-type or non-
block-type (patchy), following the guidelines of The
Lowe r Anogen i t a l Squamous Te rmino logy
Standardization Project (LAST) [16]. Block-type p16-ex-
pression is considered to be indicative of a high-risk
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HPV-infection [16]. This pattern was not present in any
slide, confirming that the selection did not contain any
HPV-related lesion.
(ii) p53-IHC patterns were scored as p53-mutant or p53-
wild-type, following recent literature [17, 18]. p53-
mutant patterns include basal to para-basal/diffuse over-
expression, basal overexpression, null-pattern, or cyto-
plasmic expression, and these have been reported to
strongly correlate with the presence of TP53 mutations
[17–19]. Presence of any of these patterns, therefore, can
be considered supportive of a histological diagnosis of
dVIN.
p53-wild-type pattern, i.e., scattered, heterogeneous,
basal/para-basal expression, is primarily seen in non-
dysplastic lesions. However, this pattern has been also
occasionally observed in dVIN [15, 20–23]. Hence, a
p53-wild-type pattern does not preclude a histological
diagnosis of dVIN. p53 patterns observed in our slides
are presented in the “Results.”
Next, a list of histological features of dVIN was compiled
from previously published literature [13–15, 24–26], and in-
corporated into an assessment form. These comprised
A. Features of nuclear atypia: (i) atypia discernable under ×
100 magnification; (ii) angulated nuclei; (iii)
macronucleoli, i.e., nucleoli visible under × 100 magni-
fication; (iv) chromatin abnormality (open or
hyperchromatic pattern); (v) multinucleation; (vi)
suprabasal mitoses; (vii) atypical mitoses; and (viii) mi-
totic count >5/5 mm
B. Features of disturbed maturation/architecture: (i) individ-
ual cell keratinization; (ii) deep keratinization; (iii) deep
squamous eddies, i.e., abortive pearls of keratin; (iv) cob-
blestone appearance, i.e., combination of premature kera-
tinization and spongiosis; (v) elongated and/or anasto-
mosing rete ridges; (vi) altered cellular alignment; and
(vii) parakeratosis.
Participants
Pathologists who attend the gynecological-pathology working
group of the Rotterdam region were invited to participate. HE-
stained glass slides were circulated among the participants for
histological assessment. Instructions and forms for the assess-
ment (supplementary document 2) were sent to the partici-
pants electronically. Clinical information, original diagnoses,
or IHC results were not provided. There was no consensus
meeting prior to the assessment to determine any diagnostic
criteria. To allow the participants to interpret the histological
features in light of their own experience, detailed instructions
regarding this were not provided. For measuring 5 mm to
assess the mitotic count, participants could use an eye-piece
graticule, or the field-diameter of the eye-pieces of their mi-
croscopes. Since the measure of 5 mm was an arbitrarily cho-
sen cut-off, a rough estimate of this measurement was consid-
ered sufficient. The participants were masked from each
other’s assessments. Information regarding the nature of prac-
tice (academic/non-academic), country of practice, and length
of practicing experience was gathered from the participants.
Histological assessment
Participants were asked to independently examine the areas
marked on the slides, and:
(i) Provide a diagnosis as – dVIN or no-dysplasia
(ii) Score the histological features (listed above) as – not
present or present, and if present, indicate whether they
were useful, or very useful for the diagnosis of dVIN
(iii) Indicate whether the diagnosis was easy or difficult
Ethics statement
This study was conducted in accordance with the guidelines of
the Dutch Federation of Biomedical Scientific Societies
(www.federa.org/codes-conduct), which state that no
separate ethical approval is required for the use of
anonymized residual tissue procured during regular treatment.
Statistical analysis
Data were analyzed after all participants had completed their
assessments, using R Core Team (2020) (Version 4.0.0,
https://www.R-project.org/). Histological diagnoses and
features were assessed categorically. Inter-observer agreement
was measured by computing (i) percentages of agreement – to
obtain an absolute measure, and (ii) kappa (ĸ) statistics – to
obtain a relative measure. Fleiss’ ĸ was computed to measure
the overall agreement, i.e., agreement among all participants,
using packages “irr” and “raters” [27, 28]. Cohen’s ĸ was
computed to measure the agreement between each participant
pair; this resulted in 36 ĸ-values for the diagnoses, as well as
for each of the 15 histological features. Cohen’s ĸ was also
used to measure the concordance of the p53-IHC patterns with
the consensus diagnoses. Bootstrapping (10,000 runs) was
performed to calculate the 95% confidence intervals (CI) of
the ĸ-values using the package “boot” [29]. ĸ-values were
interpreted as follows: < 0.20 = slight, 0.21–0.40 = fair, 0.
41–0.60 = moderate, 0.61–0.80 = substantial, or 0.81–1.00 =
near-perfect agreement. Correlation between categorical vari-
ables was measured with chi (χ2)-squared test; two-sided p-
value < 0.05 was considered statistically significant. Heat




Nine pathologists participated in this study; 6 practice at 5
non-academic centers in the Netherlands, which handle a high
diagnostic case load, and 3 practice at 2 academic centers in
Belgium. Lengths of their practice experience ranged from
less than 5 years (n = 2) to more than 15 years (n = 3). All
participants routinely read vulvar pathology cases, including
dVIN and VSCC, in their practice. The participants have been
anonymized and are represented by acronyms (P1–P9), which
do not correspond to their order in the author list.
Histological assessment
The participants diagnosed 28–81% (median = 58%) of the
slides as dVIN, and perceived 21–80% (median = 58%) of
these diagnoses to be difficult (Fig. 1). Nineteen to 72% (me-
dian = 42%) of the slides were diagnosed as no-dysplasia, of
which 6–73% (median = 29%) were perceived as difficult.
Consensus diagnoses and diagnostic agreement for dVIN
The consensus diagnosis for 23 slides (64%) was dVIN (Fig.
2). For these slides, rates of diagnostic agreement ranged from
56 to 100% (median = 78%). Unanimous agreement (100%)
was obtained for 5 slides.
The consensus diagnosis for 13 (36%) slides was no-
dysplasia (Fig. 2). For these slides, rates of diagnostic agree-
ment ranged from 67 to 100% (median = 89%). Unanimous
agreement was obtained for 4 slides.
The overall agreement for the diagnosis of dVIN was mod-
erate (ĸ = 0.42), and the pair-wise agreements ranged from
slight (ĸ = 0.10) to substantial (ĸ = 0.73) (Table 1).
Substantial agreement was obtained between 19%, and mod-
erate agreement between 39% of the participant pairs (Fig. 2).
Pair-wise ĸ-values with 95% CI are provided in Table S1. The
diagnosis of dVIN was more frequently perceived to be diffi-
cult than the diagnosis of no-dysplasia (p = 0.02). For all slides
(dVIN or no-dysplasia), diagnostic difficulty perceived by the
participants correlated significantly with lower percentages of
agreement (p = 0.001).
Correlation of the consensus diagnoses with p53-IHC patterns
Of the slides with a consensus diagnosis of dVIN, 17 (74%)
showed p53-mutant patterns, which were basal to para-basal/
diffuse overexpression in 15 slides, basal overexpression in 1
slide, and null-pattern in 1 slide. Six slides (26%) showed p53-
wild-type pattern, i.e., scattered, heterogeneous, basal/para-
basal expression (Fig. 2).
All slides with a consensus diagnosis of no-dysplasia
showed p53-wild-type pattern, i.e., scattered, heterogeneous,
basal/para-basal expression (Fig. 2). Concordance of the p53-
IHC patterns with the consensus diagnoses was substantial (ĸ
= 0.67; p < 0.001).
Agreements in the interpretation of histological features
and ratings of their usefulness
Overall agreement was moderate in the interpretation of
parakeratosis, mitotic count > 5/5 mm, and atypia discernable
under × 100 magnification. Fair agreement was obtained for
multinucleation, angulated nuclei, chromatin abnormality,
suprabasal mitoses, deep squamous eddies, elongated and/or
Fig. 1 Bar chart depicting the
proportions of slides diagnosed as
dVIN or no-dysplasia per
participant (P1–P9), along with
the proportion of slides perceived
as diagnostically difficult; the
numbers depict the percentages of
slides perceived as difficult
Fig. 2 Left: Heat map depicting the types of specimens, diagnoses
rendered by the participants (P1–P9), p53-IHC results, and the
consensus diagnoses; *, ‡, § slides were from the same specimen.
Right: Heat map depicting the levels of agreement between the




anastomosing rete ridges, altered cellular alignment, individ-
ual cell keratinization, and cobblestone appearance (Table 1).
Pair-wise agreements in the interpretation of the histologi-
cal features ranged from slight (ĸ = 0.01) to near-perfect (ĸ =
0.94) (Table 1). The highest proportion of substantial/near-
perfect agreement between participant pairs was obtained for
parakeratosis (39%), and cobblestone appearance was rated
most frequently (24%) as “very useful” for the diagnosis of
dVIN (Table 2). Taking into consideration the levels of pair-
wise agreements and the ratings of usefulness, the most help-
ful features were parakeratosis, cobblestone appearance, chro-
matin abnormality, angulated nuclei, atypia discernable under
× 100, and altered cellular alignment.
For each histological feature, the levels of pair-wise agree-
ments are depicted in Figures S1 and S2, and the pair-wise ĸ-
values with 95% CI are provided in Tables S2–S16. The rat-
ings of usefulness are depicted in Fig. 3, and the histological
features are demonstrated in Figs. 4 and 5.
Discussion
To the best of our knowledge, this is the first bi-national,
multi-institutional, ring-study to assess the inter-observer
agreement in the histological assessment of dVIN.
Agreement on the diagnosis between nine participating
pathologists was moderate, while that between the participant
pairs varied from slight to substantial. These results were sim-
ilar to that of the only previous study on inter-observer agree-
ment in dVIN [13], and indicate that the diagnostic agreement
for dVIN remains suboptimal.
As histological diagnoses guide treatment decisions, vari-
ability in the diagnoses can result in treatment disparities [31].
Therefore, to improve the diagnostic reliability and to assure a
similar standard of care, we suggest consensus evaluation of
dVIN cases with a panel of pathologists experienced in vulvar
neoplasia. Regular inter-disciplinary communication between
gynecologists/dermatologists and pathologists can also en-
hance relevant knowledge and expertise.
An essential step to ensure a reliable histological diagnosis
is to identify representative features which can be reproduc-
ibly interpreted by pathologists. We identified the most help-
ful features as parakeratosis, cobblestone appearance, chroma-
tin abnormality, angulated nuclei, atypia discernable under ×
100, and altered cellular alignment, based on the proportions
of substantial/near-perfect agreement between the participant
pairs, and the ratings of diagnostic usefulness. We observed
that the participants recorded parakeratosis and cobblestone
appearance as very useful for diagnosing dVIN, particularly
where the nuclear atypia could not be discerned under × 100.
Previously, van den Einden et al. proposed that the pres-
ence of atypical mitoses in the basal layer, basal cellular










I. Histological diagnosis 0.42 (0.40–0.49) Moderate 0.10–0.73
II. Histological features
A. Nuclear atypia
i. Atypia discernable under × 100
magnification
0.42 (0.33–0.46) Moderate 0.06–0.70
ii. Angulated nuclei 0.32 (0.29–0.35) Fair 0.01–0.65
iii. Macronucleoli 0.10 (0.04–0.13) Slight 0.01–0.68
iv. Chromatin abnormality 0.32 (0.27–0.37) Fair 0.08–0.67
v. Multinucleation 0.34 (0.32–0.41) Fair 0.01–0.87
vi. Suprabasal mitoses 0.28 (0.22–0.31) Fair 0.01–0.61
vii. Atypical mitoses 0.11 (0.04–0.14) Slight 0.01–0.91
viii. Mitotic count >5/5 mm 0.45 (0.38–0.51) Moderate 0.01–0.94
B. Disturbed maturation and architecture
i. Individual cell keratinization 0.21 (0.17–0.24) Fair 0.01–0.46
ii. Deep keratinization 0.19 (0.13–0.21) Slight 0.01–0.48
iii. Deep squamous eddies 0.31 (0.23–0.42) Fair 0.06–0.60
iv. Cobblestone appearance 0.22 (0.19–0.27) Fair 0.10–0.61
v. Elongated and/or anastomosing rete ridges 0.30 (0.22–0.35) Fair 0.04–0.69
vi. Altered cellular alignment 0.23 (0.18–0.29) Fair 0.01–0.73
vii. Parakeratosis 0.57 (0.49–0.61) Moderate 0.17–0.82
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atypia, dyskeratosis, prominent nucleoli, and elongated and
anastomosing rete ridges were the most predictive features
of dVIN [13]. In a subsequent survey among vulva pathology
experts, only basal layer atypia was judged by consensus as an
“essential” diagnostic feature [14]. However, neither of these
studies assessed the agreement in the interpretation of these
features. In our previous study, we obtained substantial agree-
ment in the interpretation of macronucleoli, angulated nuclei,
individual cell keratinization, deep keratinization, and deep
squamous eddies, between pathologists at our center [15]. In
the current study, however, similar level of agreement for
these features was not observed. We speculate that our previ-
ous results may have been influenced by the similar standard
of histological interpretation among participants who work in
close collaboration at the same center.
In this study, we also correlated the histological consensus
diagnoses with the immunohistochemical expression of p53,
as this marker is commonly used to aid the diagnosis of dVIN.
p53-mutant patterns have been reported to accurately reflect
underlying TP53mutations, which characterize dVIN [19, 20,
32]. Substantial concordance of p53-IHC patterns with the
histological consensus diagnoses was recorded, which con-
firms that routine use of this marker can improve the diagnos-
tic accuracy for dVIN.
However, 6 (26%) of the slides in this study that were
diagnosed as dVIN by consensus, showed wild-type p53-
Table 2 Histological features of
dVIN, in descending order of the
proportions of substantial/almost-
perfect agreement, and ratings as
“very useful” for diagnosis
Proportion of substantial/near-perfect agreement Very useful for the diagnosis of dVIN
1. Parakeratosis (39%) 1. Cobblestone appearance (24%)
2. Mitotic count > 5/5 mm (19%) 2. Parakeratosis (19%)
3. Deep squamous eddies (14%) 3. Angulated nuclei (18%)
4. Multinucleation (11%) 4. Atypia discernable under × 100 (16%)
5. Chromatin abnormality (8%) 5. Chromatin abnormality (16%)
6. Atypical mitoses (8%) 6. Elongated and/or anastomosing rete ridges (13%)
7. Atypia discernable under × 100 (6%) 7. Altered cellular alignment (12%)
8. Angulated nuclei (6%) 8. Individual cell keratinization (12%)
9. Macronucleoli (6%) 9. Suprabasal mitoses (11%)
10. Cobblestone appearance (6%) 10. Deep keratinization (10%)
11. Altered cellular alignment (6%) 11. Macronucleoli (9%)
12. Elongated and/or anastomosing rete ridges (5%) 12. Multinucleation (3%)
13. Suprabasal mitoses (3%) 13. Mitotic count > 5/5 mm (3%)
14. Individual cell keratinization (0%) 14. Atypical mitoses (3%)
15. Deep keratinization (0%) 15. Deep squamous eddies (2%)
Fig. 3 Bar charts representing the proportions of ratings of usefulness for each histological feature; *elongated and/or anastomosing rete ridges
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expression. This is in line with recent literature, which states
that 17–42% cases of dVIN can show wild-type p53-expres-
sion [4], and implies that p53-IHC may not effectively inform
the diagnosis in every case of dVIN. Furthermore, p53-IHC
patterns in VSCC and the adjacent dVIN may not show per-
fect concordance [22]. A recent study reported that while
dVIN adjacent to p53-wild-type VSCC always shows wild-
type p53-expression, dVIN adjacent to p53-mutant VSCC can
show wild-type p53-expression in 31.4% of cases [22]. In our
study, all of the lesions judged as dVIN by consensus and
showing wild-type p53-expression were present adjacent to
VSCC. Similarly to the previous study [22], we observed that
67% (4/6) of these VSCCs showed wild-type p53-expression,
while 33% (2/6) showed p53-mutant patterns (results not pre-
sented). This limitation of p53-IHC should be borne in mind
particularly when using this marker to confirm the presence of
dVIN in resection margins of VSCC. For dVINs that show
wild-type p53-expression, the diagnosis defers to histological
assessment, which, as our study indicates, may be fraught with
variability. In view of this, we believe that ancillary bio-
markers (immunohistochemical/molecular) need to be
established to aid the diagnosis of the p53-wild-type subcate-
gory of dVIN.
Through this study, we intended to estimate the diagnostic
variability of dVIN in the real world. To ensure an accurate
representation of this variability, (i) pathologists with varying
levels of experience and from academic and non-academic
centers were included, (ii) diagnostic criteria were not pre-
determined to allow the participants to interpret the histology
in light of their own experience, and (iii) assessments of out-
lier participants were not excluded.
Nevertheless, there are several limitations of this study.We
used the majority (consensus) diagnosis of each slide to deter-
mine the diagnostic gold standard. It could be argued whether
the consensus represents another diagnostic opinion rather
than a standard of truth. dVIN is known to originate in a
background of chronic dermatoses, and there is no clear, uni-
versally accepted threshold for identifying atypia/dysplasia.
This threshold is often influenced by the pathologists’ training
and/or practice experience. Unless a reliable IHC marker is
established, every method to ascertain a gold-standard diag-
nosis will have some bias.
Fig. 4 Low- (A) and high-magnification (B and C) images of one of the
slides (HE-stain) that was diagnosed by all participants as dVIN, with
corresponding p53-IHC (D). (A) Epithelial acanthosis, hyperkeratosis,
parakeratosis, and an eosinophilic appearance can be appreciated under
low magnification (original magnification × 5). (B) Cobblestone
appearance (circled area), deep squamous eddies (arrow), elongated rete
ridges, and (C) altered cellular alignment and angulated nuclei (squared
area) were rated by the participants as “very useful” features for the
diagnosis for this slide (original magnification × 200); (D) p53-IHC
shows a wild-type pattern, i.e., scattered nuclear p53 staining of
heterogeneous intensity in the basal and the para-basal layers
Virchows Arch
There is also little consensus on the ideal method for mea-
suring observer agreement in pathology diagnosis. It has been
suggested that both percentages of agreement and ĸ-statistics
do not take into account the prevalence of a particular diag-
nosis in a set of cases, or completely rule out concordances
due to chance [33, 34]. Validity of the cut-offs that are used to
interpret levels of agreement from ĸ-values has also been chal-
lenged [30, 35].
It could also be argued whether our study over-
estimated the diagnostic variability. Unlike in routine
practice, participants diagnosed the slides without clinical
information, serial sections, or IHC. The selection
contained a higher proportion of dVIN than no-dysplasia
slides, which may not reflect routine practice. We lacked
statistical power to evaluate the influence of level of ex-
perience or practice setting on the diagnostic variability.
Furthermore, the inter-observer agreement in the interpre-
tation of p53-IHC was not assessed. To gain further in-
sights on these contexts, we have set up a larger study
among geographically disparate group of pathologists,
which includes the assessment of p53-IHC.
In conclusion, the suboptimal level of diagnostic agree-
ment for dVIN observed in this study affirms the difficulty
of the diagnosis. We identified parakeratosis, cobblestone ap-
pearance, chromatin abnormality, angulated nuclei, atypia dis-
cernable under × 100, and altered cellular alignment as helpful
diagnostic features of dVIN. For cases with a histological
suspicion of dVIN, we suggest consensus-based pathological
evaluation to improve diagnostic reliability.
Supplementary Information The online version contains supplementary
material available at https://doi.org/10.1007/s00428-021-03070-0.
Acknowledgements The authors are grateful to Mr. Hongchao Qi,
Statistical Consultant, Department of Bio-statistics, Erasmus MC, for his
guidance on the data analyses, and to Dr. Thierry P.P. van den Bosch, Dr.
RemkoHersmus, andMs. Linda Coelers, from the Department of Pathology,
Erasmus MC, for their excellent technical assistance.
Author contribution Conceptualization: S. Dasgupta, P.C. Ewing-
Graham, S. Koljenović, F.J. van Kemenade; methodology: S. Dasgupta,
P.C. Ewing-Graham, F.J. van Kemenade; software, formal analysis, vi-
sualization: S. Dasgupta; data curation: S. Dasgupta, P.C. Ewing-
Graham, E. de Jonge, M.R. Van Bockstal, L.S.M. Wong-Alcala, S.
Wilhelmus, L.A.C.F. Makkus, K. Schelfout, K.K. Van de Vijver, S.
Smits, E. Marbaix; writing – original draft preparation: S. Dasgupta;
writing – review and editing: all authors; supervision: P.C. Ewing-
Graham, S. Koljenović, F.J. van Kemenade
Data Availability Whole slide images of the cases included in this study
are available for sharing with physicians and researchers for educational
and research purposes. Upon reasonable request, images will be shared in
a secure manner, obeying our hospital guidelines. Requests can be direct-
ed to the corresponding author.
Fig. 5 Low- (A) and high-
magnification (B) images of one
of the slides (HE-stain) that was
diagnosed by 5 participants as
dVIN and 4 participants as no-
dysplasia, with corresponding
p53-IHC (C). (A) Elongated rete
ridges and hyperkeratosis are
appreciable under low
magnification (original
magnification × 5). (B)
Participants who diagnosed this
slide as dVIN rated angulated
nuclei, chromatin abnormality,
cobblestone appearance,
elongated rete ridges, and altered
cellular alignment as “very
useful” features for the diagnosis
(original magnification × 300);
(C) p53-IHC shows mutant
pattern, i.e., diffuse, strong,
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